Skip to main content



Alexander Lim, MD, is a hematologist/oncologist at our Southpoint location. Originally from Gainesville, Dr. Lim earned his Bachelor of Science in Biology and his Doctor of Medicine from the University of Central Florida. After completing his internal medicine residency at the University of South Florida, he moved home to Gainesville to attend the University of Florida for his Hematology/Oncology fellowship.

During his first year of college, Dr. Lim’s father was diagnosed with pancreatic cancer:

“I never looked away from the oncology field after that,” he explains. “My dean in medical school taught me that you can make the most precise plan with the best data available, but if the patient in front of you is unable to meet that plan for some reason, then it’s not a good one. I took that advice to heart, and if ever the plan goes bad, I think of my dad. How would I want him, or any other family member, to be treated? How would I want to treat my family member?”

“I see my family in all of my patients,” he continues. “There’s nothing unimportant that a patient can say to me. Our scheduled time in the exam room is for them and their families to ask as many questions and share as many hopes, needs, and fears as they feel necessary.”

Having lived around the North Florida area his entire life, CSNF wasn’t new to him:

“CSNF’s reputation, per the university and colleagues was consistent: they are good people who put their patients first. That’s what I always envisioned for myself when seeking a company to call my home – colleagues who are going to treat their patients the same way I plan to: like family.”

When not in the office, Dr. Lim enjoys running and spending time with his dogs, Beau and Pepper.

Curriculum Vitae


Internal Medicine


University of Florida


University of South Florida


University of Central Florida
Doctor of Medicine
University of Central Florida
Bachelor of Science, Biology


Journal of Clinical Oncology
Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer.
Expert Opinion on Investig. Drugs
Novel targeted treatment options for advanced cholangiocarcinoma
Journal of Clinical Oncology
Relationship between tumor-infiltrating lymphocytes (TIL) and absolute lymphocyte count (ALC) or lymphocyte to neutrophil ratio (LTN) in cholangiocarcinoma (CCA
Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS.
Annals of Global Health
) Electronic health record integration in an interdisciplinary short-term medical service to the Dominican Republic